The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study

INTRODUCTION: The curative treatment approach for diffuse large B-cell lymphoma (DLBCL) is controversial even in the rituximab (R) era. The aim of this study was to examine the FcγRIIIA gene polymorphism distribution of DLBCL patients who had been treated with R-CHOP (cyclophosphamide, doxorubi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nurhilal Büyükkurt, Mehmet Ali Özcan, Ülkü Ergene, Bahriye Payzın, Sunay Tunalı, Fatih Demirkan, Hayri Özsan, Özden Pişkin, Bülent Ündar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Turkish Society of Hematology 2015-05-01
Colecção:	Turkish Journal of Hematology
Assuntos:	fcγ riiia diffuse large b-cell lymphoma rituximab
Acesso em linha:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-66587
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!